Resistance to gemcitabine is mediated by the circ_0036627/ miR ‐145/ S100A16 axis in pancreatic cancer
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Shuo Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, H…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Gemcitabine, Gene Expression Regulation, Neoplastic, MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The development of gemcitabine (GEM) resistance severely limits the treatment efficacy in pancreatic cancer (PC) and increasing evidence highlights the vital roles of circular RNAs (circRNAs) in the tumorigenesis, progression and drug resistance of PC. However, the circRNAs underlying GEM resistance development of PC remains to be clarified. The current research aims to unveil the roles of circ_0036627 in dictating the aggressiveness and GEM sensitivity in PC. We reported the increased expression of circ_0036627 in PC tissues and PC cell lines. Elevated circ_0036627 expression level was correlated with advanced tumour grade and poor overall survival in PC patients. Functional assays and in vivo experiments demonstrated that circ_0036627 overexpression was required for the proliferation, migration invasion and GEM resistance in PC cells. circ_0036627 knockdown suppressed tumour development in vivo. The molecular analysis further showed that circ_0036627 increased S100A16 expression by sponging microRNA‐145 (miR‐145), a tumour‐suppressive miRNA that could significantly attenuate PC cell proliferation, migration, invasion and GEM resistance. Furthermore, our findings suggested that S100A16 acted as an oncogenic factor to promote aggressiveness and GEM resistance in PC cells. In conclusion, the current findings provide new mechanistic insights into PC aggressiveness and GEM resistance, suggesting the critical role of circ_0036627/miR‐145/S100A16 axis in PC progression and drug resistance development and offering novel therapeutic targets for PC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
ORCID-Profile: Renyi Qin
Zitieren
APA
Yu, S., Wang, M., Zhang, H., Guo, X., & Qin, R. (2024). Resistance to gemcitabine is mediated by the circ_0036627/ miR ‐145/ S100A16 axis in pancreatic cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18444
Vancouver
Yu S, Wang M, Zhang H, Guo X, Qin R. Resistance to gemcitabine is mediated by the circ_0036627/ miR ‐145/ S100A16 axis in pancreatic cancer. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18444
BibTeX
@article{Yu2024,
author = {Yu, Shuo and Wang, Min and Zhang, Hang and Guo, Xingjun and Qin, Renyi},
title = {Resistance to gemcitabine is mediated by the circ_0036627/ miR ‐145/ S100A16 axis in pancreatic cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18444}
}
EUVIMED